Obstructive sleep apnea and cardiovascular disease

Cardiology in Review

Volumn 19, Issue 6, 2011, Pages 279-290

  Gopalakrishnan, Prabhakaran ^a   Tak, Tahir ^b  

^a JPS Health Network   (United States)

^b MAYO CLINIC   (United States)

Author keywords

atrial fibrillation; cardiovascular disease; congestive heart failure; continuous positive airway pressure; coronary artery disease; hypertension; metabolic syndrome; obstructive sleep apnea; sleep disordered breathing; stroke

Indexed keywords

ADENOIDECTOMY; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; GAS EXCHANGE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INFLAMMATION; LUNG HEMODYNAMICS; LUNG MECHANICS; MANDIBLE OSTEOTOMY; MAXILLA OSTEOTOMY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; REVIEW; SLEEP APNEA SYNDROME; STROKE; TONSILLECTOMY; TRACHEOSTOMY; UVULOPALATOPHARYNGOPLASTY;

CARDIOVASCULAR DISEASES; HUMANS; SLEEP APNEA, OBSTRUCTIVE;

EID: 80054023242     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318223bd08     Document Type: Review

References (225)

1. Gastaut H, Tassinari CA, Duron B. Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome. Rev Neurol (Paris). 1965;112:568-579.
2. Jung R, Kuhlo W. Neurophysiological studies of abnormal night sleep and the pickwickian syndrome. Prog Brain Res. 1965;18:140-159.
3. Bickelmann AG, Burwell CS, Robin ED, et al. Extreme obesity associated with alveolar hypoventilation: A Pickwickian syndrome. Am J Med. 1956; 21:811-818.
4. Paramelle B, Faure J, Yacoub M, et al. Hypersomnolence of plethori subjects as a possible cause of traffic accidents [in French]. Med Leg Dommage Corpor. 1968;1:423-426.
5. Guilleminault C, Cummiskey J, Dement WC. Sleep apnea syndrome: Recent advances. Adv Intern Med. 1980;26:347-372.
6. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: A systematic review of the research evidence. BMJ. 1997;314:851-860. (Pubitemid 27182017)
7. Silverberg D, Oksenberg A, Iaina A. The Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure and obstructive sleep apnea: Let their silence not be matched by the silence of the ordinary physician. Arch Intern Med. 1998;158:1272-1273. (Pubitemid 28252494)
8. Fleetham J, Ayas N, Bradley D, et al. Canadian Thoracic Society guidelines: Diagnosis and treatment of sleep disordered breathing in adults. Can Respir J. 2006;13:387-392. (Pubitemid 44781741)
9. Berry RB, Gleeson K. Respiratory arousal from sleep: Mechanisms and significance. Sleep. 1997;20:654-675. (Pubitemid 27449605)
10. Chung JW, Enciso R, Levendowski DJ, et al. Patients with positional versus nonpositional obstructive sleep apnea: A retrospective study of risk factors associated with apnea-hypopnea severity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:605-610.
11. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: A tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812-821. (Pubitemid 351589476)
12. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anaesth. 2010;57:423-438.
13. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52:686-717.
14. Kapur V, Blough DK, Sandblom RE, et al. The medical cost of undiagnosed sleep apnea. Sleep. 1999;22:749-755. (Pubitemid 29445342)
15. Kapur V, Strohl KP, Redline S, et al. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath. 2002;6:49-54. (Pubitemid 34752698)
16. Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20:705-706. (Pubitemid 27506200)
17. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235. (Pubitemid 23115702)
18. Schwab J. Sex differences and sleep apnoea. Thorax. 1999;54:284-285.
19. Meetze K, Gillespie MB, Lee FS. Obstructive sleep apnea: A comparison of black and white subjects. Laryngoscope. 2002;112:1271-1274. (Pubitemid 34747228)
20. Villaneuva AT, Buchanan PR, Yee BJ, et al. Ethnicity and obstructive sleep apnoea. Sleep Med Rev. 2005;9:419-436. (Pubitemid 41630721)
21. Friedman M, Bliznikas D, Klein M, et al. Comparison of the incidences of obstructive sleep apnea-hypopnea syndrome in African-Americans versus Caucasian-Americans. Otolaryngol Head Neck Surg. 2006;134:545-550.
22. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015-3021. (Pubitemid 32014738)
23. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-1384. (Pubitemid 30262394)
24. Eckert DJ, Malhotra A, Jordan AS. Mechanisms of apnea. Prog Cardiovasc Dis. 2009;51:313-323.
25. Obstructive sleep apnea and blood pressure elevation: What is the relationship? Working Group on OSA and Hypertension. Blood Press. 1993;2:166-182.
26. Buda AJ, Schroeder JS, Guilleminault C. Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol. 1981;1:67-74. (Pubitemid 11019048)
27. White DP, Weil JV, Zwillich CW. Metabolic rate and breathing during sleep. J Appl Physiol. 1985;59:384-391. (Pubitemid 15249864)
28. Somers VK, Dyken ME, Mark AL, et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328:303-307. (Pubitemid 23035328)
29. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.
30. Shepard JW Jr. Gas exchange and hemodynamics during sleep. Med Clin North Am. 1985;69:1243-1264. (Pubitemid 16199958)
31. Mancia G. Autonomic modulation of the cardiovascular system during sleep. N Engl J Med. 1993;328:347-349. (Pubitemid 23035336)
32. Blix AS, Gautvik EL, Refsum H. Aspects of the relative roles of peripheral vasoconstriction and vagal bradycardia in the establishment of the "diving reflex" in ducks. Acta Physiol Scand. 1974;90:289-296.
33. Hanly PJ, George CF, Millar TW, et al. Heart rate response to breath-hold, valsalva and Mueller maneuvers in obstructive sleep apnea. Chest. 1989;95:735-739. (Pubitemid 19102875)
34. Somers VK, Dyken ME, Skinner JL. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans. J Auton Nerv Syst. 1993;44:253-259. (Pubitemid 23273009)
35. Smith RP, Veale D, Pepin JL, et al. Obstructive sleep apnoea and the autonomic nervous system. Sleep Med Rev. 1998;2:69-92. (Pubitemid 128646698)
36. Spiegel K, Tasali E, Leproult R, et al. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol. 2009;5:253-261.
37. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:1151-1158. (Pubitemid 32269364)
38. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165: 670-676. (Pubitemid 34194755)
39. Steiropoulos P, Papanas N, Nena E, et al. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: Does adherence to CPAP treatment improve glycemic control? Sleep Med. 2009;10:887-891.
40. Leproult R, Copinschi G, Buxton O, et al. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20:865-870. (Pubitemid 27524715)
41. Ganjavi H, Shapiro CM. Hypocretin/Orexin: A molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci. 2007;19: 413-419. (Pubitemid 350156099)
42. Sakurai S, Nishijima T, Takahashi S, et al. Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome. Respiration. 2004;71:380-384. (Pubitemid 39179174)
43. Sakurai S, Nishijima T, Takahashi S, et al. Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127:731-737. (Pubitemid 40775499)
44. Busquets X, Barbe F, Barcelo A, et al. Decreased plasma levels of orexin-A in sleep apnea. Respiration. 2004;71:575-579. (Pubitemid 40091429)
45. Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev. 2005;9:231-241. (Pubitemid 40982495)
46. Sakurai T. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS Neurol Disord Drug Targets. 2006;5:313-325. (Pubitemid 43884171)
47. Van CE, Spiegel K, Tasali E, et al. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008;9(suppl 1):S23-S28.
48. Spiegel K, Tasali E, Penev P, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004; 141:846-850. (Pubitemid 39601178)
49. Palmblad J, Akerstedt T, Froberg J, et al. Thyroid and adrenomedullary reactions during sleep deprivation. Acta Endocrinol (Copenh). 1979;90:233-239. (Pubitemid 9112392)
50. Gary KA, Winokur A, Douglas SD, et al. Total sleep deprivation and the thyroid axis: Effects of sleep and waking activity. Aviat Space Environ Med. 1996;67:513-519. (Pubitemid 26243368)
51. Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16:274-280. (Pubitemid 36384754)
52. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131:453-459.
53. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension. 1999;34:309-314. (Pubitemid 29409233)
54. Calhoun DA, Nishizaka MK, Zaman MA, et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125:112-117. (Pubitemid 38114572)
55. Irwin M, Thompson J, Miller C, et al. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: Clinical implications. J Clin Endocrinol Metab. 1999;84:1979-1985. (Pubitemid 30647021)
56. Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med. 2010;6:363-368.
57. Peng Y, Yuan G, Overholt JL, et al. Systemic and cellular responses to intermittent hypoxia: Evidence for oxidative stress and mitochondrial dysfunction. Adv Exp Med Biol. 2003;536:559-564. (Pubitemid 37494660)
58. McGown AD, Makker H, Elwell C, et al. Measurement of changes in cytochrome oxidase redox state during obstructive sleep apnea using nearinfrared spectroscopy. Sleep. 2003;26:710-716. (Pubitemid 39619781)
59. Trenam CW, Dabbagh AJ, Morris CJ, et al. Skin inflammation induced by reactive oxygen species (ROS): An in-vivo model. Br J Dermatol. 1991;125: 325-329.
60. Khodr B, Khalil Z. Modulation of inflammation by reactive oxygen species: Implications for aging and tissue repair. Free Radic Biol Med. 2001;30:1-8. (Pubitemid 32008083)
61. Fresquet F, Pourageaud F, Leblais V, et al. Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol. 2006;148:714-723. (Pubitemid 43996780)
62. Ruef J, Hu ZY, Yin LY, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res. 1997;81:24-33. (Pubitemid 27272979)
63. Cahilly C, Ballantyne CM, Lim DS, et al. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res. 2000;86:391-395. (Pubitemid 30141757)
64. Sedeek MH, Llinas MT, Drummond H, et al. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension. 2003;42:806-810. (Pubitemid 37237329)
65. Armando I, Wang X, Villar VA, et al. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension. 2007; 49:672-678.
66. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-163. (Pubitemid 15192863)
67. Htoo AK, Greenberg H, Tongia S, et al. Activation of nuclear factor kappaB in obstructive sleep apnea: A pathway leading to systemic inflammation. Sleep Breath. 2006;10:43-50. (Pubitemid 44193436)
68. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endotheliumdependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102:2607-2610.
69. Fletcher EC, Lesske J, Qian W, et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension. 1992;19:555-561.
70. Dematteis M, Godin-Ribuot D, Arnaud C, et al. Cardiovascular consequences of sleep-disordered breathing: Contribution of animal models to understanding the human disease. ILAR J. 2009;50:262-281.
71. Belaidi E, Joyeux-Faure M, Ribuot C, et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol. 2009;53:1309-1317.
72. Young T, Peppard P, Palta M, et al. Population-based study of sleepdisordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-1752. (Pubitemid 27327411)
73. Hla KM, Young T, Finn L, et al. Longitudinal association of sleepdisordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep. 2008;31:795-800. (Pubitemid 351810508)
74. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829-1836. (Pubitemid 30207619)
75. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572. (Pubitemid 37430158)
76. Thomas RJ, Weiss MD, Mietus JE, et al. Prevalent hypertension and stroke in the Sleep Heart Health Study: Association with an ECG-derived spectrographic marker of cardiopulmonary coupling. Sleep. 2009;32:897-904.
77. O'Connor GT, Caffo B, Newman AB, et al. Prospective study of sleepdisordered breathing and hypertension: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159-1164.
78. Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, et al. Association between refractory hypertension and obstructive sleep apnea. J Hypertens. 2009;27:1439-1445.
79. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107:68-73. (Pubitemid 36070935)
80. Andren A, Sjoquist M, Tegelberg A. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance -a three-year follow-up. J Oral Rehabil. 2009;36:719-725.
81. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229-1235. (Pubitemid 44914309)
82. Jaimchariyatam N, Rodriguez CL, Budur K. Does CPAP treatment in mild obstructive sleep apnea affect blood pressure? Sleep Med. 2010;11:837-842.
83. Aihara K, Chin K, Oga T, et al. Long-term nasal continuous positive airway pressure treatment lowers blood pressure in patients with obstructive sleep apnea regardless of age. Hypertens Res. 2010;33:1025-1031.
84. Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: A randomized, controlled trial. J Hypertens. 2010;28:2161-2168.
85. Barbé F, Durán-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718-726.
86. Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med. 2009;5:103-107.
87. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438. (Pubitemid 38133916)
88. Tasali E, Van CE, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:36-42. (Pubitemid 43069114)
89. Jennings JR, Muldoon MF, Hall M, et al. Self-reported sleep quality is associated with the metabolic syndrome. Sleep. 2007;30:219-223.
90. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol. 2004;160:521-530. (Pubitemid 39215628)
91. Tamura A, Kawano Y, Watanabe T, et al. Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir Med. 2008;102:1412-1416.
92. Tasali E, Van CE, Hoffman L, et al. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:3878-3884.
93. Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes: A population-based study. Am J Respir Crit Care Med. 2005;172:1590-1595. (Pubitemid 43076551)
94. Marshall NS, Wong KK, Phillips CL, et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J Clin Sleep Med. 2009;5:15-20.
95. Cuhadaroglu C, Utkusavas A, Ozturk L, et al. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009;187:75-81.
96. Dawson A, Abel SL, Loving RT, et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med. 2008;4:538-542.
97. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007;62:969-974. (Pubitemid 350084496)
98. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154-2159. (Pubitemid 28262123)
99. Lanfranchi PA, Somers VK, Braghiroli A, et al. Central sleep apnea in left ventricular dysfunction: Prevalence and implications for arrhythmic risk. Circulation. 2003;107:727-732. (Pubitemid 36222601)
100. Ferreira S, Marinho A, Patacho M, et al. Prevalence and characteristics of sleep apnoea in patients with stable heart failure: Results from a heart failure clinic. BMC Pulm Med. 2010;10:9.
101. Paulino A, Damy T, Margarit L, et al. Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis. 2009;102:169-175.
102. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: Pathophysiologic and therapeutic implications. J Am Coll Cardiol. 2011;57:119-127.
103. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910-916.
104. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364-367. (Pubitemid 38993843)
105. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation. 2009;119:2516-2525.
106. Whipple GH, Sheffield LT, Woodman EG, et al. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc. 1962;20:39-40.
107. Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects. Circulation. 1987;75:857-867. (Pubitemid 17052671)
108. Fung JW, Li TS, Choy DK, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest. 2002;121:422-429. (Pubitemid 34132978)
109. Akar BN, Ciftci B, Durmaz T, et al. Effects of continuous positive airway pressure therapy on left ventricular function assessed by tissue Doppler imaging in patients with obstructive sleep apnoea syndrome. Eur J Echocardiogr. 2009;10:376-382.
110. Ferrier KA, Neill AM, O'Meeghan T, et al. Continuous positive airway pressure in heart failure patients with obstructive sleep apnoea. Intern Med J. 2008;38:829-836.
111. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation. 2010;122:352-360.
112. Johnson CB, Beanlands RS, Yoshinaga K, et al. Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol. 2008;24:697-704.
113. Khayat RN, Abraham WT, Patt B, et al. In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest. 2009;136:991-997.
114. Khayat RN, Abraham WT, Patt B, et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: A pilot study. Chest. 2008;134:1162-1168.
115. Dohi T, Kasai T, Narui K, et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J. 2008;72:1100-1105. (Pubitemid 351957075)
116. Smith LA, Vennelle M, Gardner RS, et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: A randomized placebo-controlled trial. Eur Heart J. 2007;28: 1221-1227. (Pubitemid 47343854)
117. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631. (Pubitemid 46551635)
118. Kasai T, Narui K, Dohi T, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest. 2008;133:690-696. (Pubitemid 351367378)
119. Luo Q, Zhang HL, Tao XC, et al. Impact of untreated sleep apnea on prognosis of patients with congestive heart failure. Int J Cardiol. 2009;144: 420-422.
120. Javaheri S, Caref EB, Chen E, et al. Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med. 2011;183:539-546.
121. Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J. 2009;73:295-298.
122. Yumino D, Wang H, Floras JS, et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail. 2009;15:279-285.
123. MacDonald M, Fang J, Pittman SD, et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with betablockers. J Clin Sleep Med. 2008;4:38-42. (Pubitemid 352038668)
124. Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol. 2004;44:68-71. (Pubitemid 38968459)
125. Stanchina ML, Ellison K, Malhotra A, et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: A pilot study. Chest. 2007;132:433-439. (Pubitemid 47282373)
126. Ryan CM, Floras JS, Logan AG, et al. Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J. 2010;35:592-597.
127. Andreas S, Schulz R, Werner GS, et al. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis. 1996;7: 541-545. (Pubitemid 26365631)
128. Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology. 1999;92:79-84. (Pubitemid 30135935)
129. Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52:343-346. (Pubitemid 352001344)
130. Tamura A, Kawano Y, Ando S, et al. Association between coronary spastic angina pectoris and obstructive sleep apnea. J Cardiol. 2010;56:240-244.
131. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:706-712. (Pubitemid 47503079)
132. Lui MM, Lam JC, Mak HK, et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest. 2009;135: 950-956.
133. von KR, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131:733-739. (Pubitemid 46446864)
134. Hamilton GS, Meredith IT, Walker AM, et al. Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans. Sleep. 2009;32:263-270.
135. Mak GS, Kern MJ, Patel PM. Influence of obstructive sleep apnea and treatment with continuous positive airway pressure on fractional flow reserve measurements for coronary lesion assessment. Catheter Cardiovasc Interv. 2010;75:207-213.
136. Gami AS, Rader S, Svatikova A, et al. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest. 2007;131:118-121. (Pubitemid 46122982)
137. Steiner S, Schueller PO, Hennersdorf MG, et al. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res. 2008;9:50.
138. Cassar A, Morgenthaler TI, Lennon RJ, et al. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:1310-1314. (Pubitemid 47446092)
139. Marin JM, Carrizo SJ, Kogan I. Obstructive sleep apnea and acute myocardial infarction: Clinical implications of the association. Sleep. 1998;21:809-815. (Pubitemid 29006521)
140. Kim SH, Cho GY, Baik I, et al. Association of coronary artery calcification with obstructive sleep apnea and obesity in middle-aged men. Nutr Metab Cardiovasc Dis. 2010;20:575-582.
141. de Araujo CM, Solimene MC, Grupi CJ, et al. Evidence that the degree of obstructive sleep apnea may not increase myocardial ischemia and arrhythmias in patients with stable coronary artery disease. Clinics (Sao Paulo). 2009;64:223-230.
142. Peker Y, Glantz H, Thunström E, et al. Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea-RICCADSA trial. Scand Cardiovasc J. 2009;43:24-31.
143. Monahan K, Storfer-Isser A, Mehra R, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol. 2009;54:1797-1804.
144. Daccarett M, Segerson NM, Hamdan AL, et al. Relation of daytime bradyarrhythmias with high risk features of sleep apnea. Am J Cardiol. 2008;101:1147-1150.
145. Garrigue S, Pepin JL, Defaye P, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: The European Multicenter Polysomnographic Study. Circulation. 2007;115:1703-1709. (Pubitemid 46648606)
146. Kesek M, Franklin KA, Sahlin C, et al. Heart rate variability during sleep and sleep apnoea in a population based study of 387 women. Clin Physiol Funct Imaging. 2009;29:309-315.
147. Park DH, Shin CJ, Hong SC, et al. Correlation between the severity of obstructive sleep apnea and heart rate variability indices. J Korean Med Sci. 2008;23:226-231.
148. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352:1206-1214.
149. Mehra R, Stone KL, Varosy PD, et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: Outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med. 2009;169:1147-1155.
150. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375. (Pubitemid 32424106)
151. Lim HE, Kim YH, Kim SH, et al. Impact of obstructive sleep apnea on the atrial electromechanical activation time. Circ J. 2009;73:249-255.
152. Mooe T, Gullsby S, Rabben T, et al. Sleep-disordered breathing: A novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 1996;7:475-478. (Pubitemid 26330652)
153. Braga B, Poyares D, Cintra F, et al. Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med. 2009;10:212-216.
154. Porthan KM, Melin JH, Kupila JT, et al. Prevalence of sleep apnea syndrome in lone atrial fibrillation: A case-control study. Chest. 2004;125: 879-885. (Pubitemid 38367277)
155. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-2594. (Pubitemid 36628941)
156. Jongnarangsin K, Chugh A, Good E, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:668-672.
157. Mazza A, Bendini MG, Cristofori M, et al. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: A predictive model based upon the multiple effects of significant variables. Europace. 2009;11: 902-909.
158. Chilukuri K, Dalal D, Marine JE, et al. Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation. Europace. 2009;11:896-901.
159. Padeletti L, Gensini GF, Pieragnoli P, et al. The risk profile for obstructive sleep apnea does not affect the recurrence of atrial fibrillation. Pacing Clin Electrophysiol. 2006;29:727-732. (Pubitemid 44060740)
160. Tang RB, Dong JZ, Liu XP, et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace. 2009;11:100-105.
161. Watanabe MA, Bhalodia R, Lundequam EJ, et al. Increased Ventricular Premature Contraction Frequency During REM Sleep in Patients with Coronary Artery Disease and Obstructive Sleep Apnea. Indian Pacing Electrophysiol J. 2008;8:258-267.
162. Fichter J, Bauer D, Arampatzis S, et al. Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest. 2002;122:558-561. (Pubitemid 35002135)
163. Tilkian AG, Guilleminault C, Schroeder JS, et al. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med. 1977;63:348-358. (Pubitemid 8190926)
164. Ryan CM, Usui K, Floras JS, et al. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60:781-785. (Pubitemid 41297899)
165. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: Effects of nasal continuous positive airway pressure therapy. Chest. 2000;118:591-595.
166. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation. 2000; 101:392-397. (Pubitemid 30067395)
167. Sanner BM, Zidek W, Laschewski F, et al. Prevalence of ventricular late potentials in patients with obstructive sleep apnea syndrome. Clin Cardiol. 1999;22:219-224. (Pubitemid 29116172)
168. Hoyer FF, Lickfett LM, Mittmann-Braun E, et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol. 2010;29: 37-41.
169. Matiello M, Nadal M, Tamborero D, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010;12: 1084-1089.
170. Chilukuri K, Dalal D, Gadrey S, et al. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:521-525.
171. Drager LF, Bortolotto LA, Krieger EM, et al. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension. 2009;53:64-69.
172. Silvestrini M, Rizzato B, Placidi F, et al. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke. 2002;33:1782-1785. (Pubitemid 34761060)
173. Nasr N, Traon AP, Czosnyka M, et al. Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. Eur J Neurol. 2009;16:386-391.
174. Furtner M, Staudacher M, Frauscher B, et al. Cerebral vasoreactivity decreases overnight in severe obstructive sleep apnea syndrome: A study of cerebral hemodynamics. Sleep Med. 2009;10:875-881.
175. Urbano F, Roux F, Schindler J, et al. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol. 2008;105:1852-1857.
176. Bernath I, McNamara P, Szternak N, et al. Hyperviscosity as a possible cause of positive acoustic evoked potential findings in patients with sleep apnea: A dual electrophysiological and hemorheological study. Sleep Med. 2009;10:361-367.
177. Peled N, Kassirer M, Kramer MR, et al. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res. 2008; 121:631-636. (Pubitemid 351305295)
178. Guardiola JJ, Matheson PJ, Clavijo LC, et al. Hypercoagulability in patients with obstructive sleep apnea. Sleep Med. 2001;2:517-523. (Pubitemid 34026951)
179. Howard RS, Rudd AG, Wolfe CD, et al. Pathophysiological and clinical aspects of breathing after stroke. Postgrad Med J. 2001;77:700-702. (Pubitemid 33016069)
180. Chaudhary BA, Elguindi AS, King DW. Obstructive sleep apnea after lateral medullary syndrome. South Med J. 1982;75:65-67. (Pubitemid 12102811)
181. McArdle N, Riha RL, Vennelle M, et al. Sleep-disordered breathing as a risk factor for cerebrovascular disease: A case-control study in patients with transient ischemic attacks. Stroke. 2003;34:2916-2921. (Pubitemid 37517769)
182. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447-1451. (Pubitemid 43069819)
183. Sonka K, Kelemen J, Kemlink D, et al. Evening and morning plasma levels of protein S100B in patients with obstructive sleep apnea. Neuro Endocrinol Lett. 2007;28:575-579.
184. Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med. 2007; 175:612-617. (Pubitemid 46438946)
185. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041. (Pubitemid 41609096)
186. Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006;37:2317-2321. (Pubitemid 44337176)
187. Valham F, Mooe T, Rabben T, et al. Increased risk of stroke in patients with coronary artery disease and sleep apnea: A 10-year follow-up. Circulation. 2008;118:955-960.
188. Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: A 10-year follow-up. Arch Intern Med. 2008;168:297-301. (Pubitemid 351281676)
189. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apneahypopnea and incident stroke: The sleep heart health study. Am J Respir Crit Care Med. 2010;182:269-277.
190. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: A 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36-41.
191. Foster GE, Hanly PJ, Ostrowski M, et al. Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2007;175:720-725. (Pubitemid 46536488)
192. Hsu CY, Vennelle M, Li HY, et al. Sleep-disordered breathing after stroke: A randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry. 2006;77:1143-1149. (Pubitemid 44453248)
193. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006;13:198-200.
194. Sajkov D, Wang T, Saunders NA, et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518-1526. (Pubitemid 29227863)
195. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:152-158. (Pubitemid 34084449)
196. Berman EJ, DiBenedetto RJ, Causey DE, et al. Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest. 1991;100:347-350.
197. Minai OA, Ricaurte B, Kaw R, et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol. 2009;104:1300-1306.
198. Randerath WJ, Galetke W, Stieglitz S, et al. Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration. Sleep Med. 2008;9:823-830.
199. Guimaraes KC, Drager LF, Genta PR, et al. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2009;179:962-966.
200. Khan A, Ramar K, Maddirala S, et al. Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: The mayo clinic experience. Mayo Clin Proc. 2009;84:795-800.
201. George LT, Barber HD, Smith BM. Maxillomandibular advancement surgery: An alternative treatment option for obstructive sleep apnea. Atlas Oral Maxillofac Surg Clin North Am. 2007;15:163-177.
202. Browaldh N, Markstrom A, Friberg D. Elective tracheostomy is an alternative treatment in patients with severe obstructive sleep apnoea syndrome and CPAP failure. Acta Otolaryngol. 2008:1-6.
203. Brigance JS, Miyamoto RC, Schilt P, et al. Surgical management of obstructive sleep apnea in infants and young toddlers. Otolaryngol Head Neck Surg. 2009;140:912-916.
204. Maurer JT. Update on surgical treatments for sleep apnea. Swiss Med Wkly. 2009;139:624-629.
205. Hamans E, Meeus O, Boudewyns A, et al. Outcome of sleep endoscopy in obstructive sleep apnoea: The Antwerp experience. B-ENT. 2010;6:97-103.
206. White J, Cates C, Wright J. Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database Syst Rev. 2002:CD001106.
207. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006:CD001106.
208. Rodway GW, Weaver TE, Mancini C, et al. Evaluation of sham-CPAP as a placebo in CPAP intervention studies. Sleep. 2010;33:260-266.
209. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007;29:720-727. (Pubitemid 46554622)
210. Schahin SP, Nechanitzky T, Dittel C, et al. Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. Med Sci Monit. 2008;14:CR117-CR121. (Pubitemid 351457407)
211. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165:447-452. (Pubitemid 40280202)
212. Lam JC, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnea. Eur Respir J. 2010;35:138-145.
213. Murri M, Alcázar-Ramírez J, Garrido-Sánchez L, et al. Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients. Transl Res. 2009;154:111-121.
214. Bayram NA, Ciftci B, Keles T, et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep. 2009;32:1257-1263.
215. Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: A randomised controlled trial. Thorax. 2008;63:578-583. (Pubitemid 351969249)
216. Ishida K, Kato M, Kato Y, et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest. 2009;136:125-129.
217. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996; 153(6 pt 1):1972-1976. (Pubitemid 26187928)
218. von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure. Sleep Breath. 2006;10:139-146. (Pubitemid 44322495)
219. Tazbirek M, Slowinska L, Skoczynski S, et al. Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters. Clin Hemorheol Microcirc. 2009;41:241-249.
220. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31:1071-1078.
221. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: The Busselton Health Study. Sleep. 2008;31: 1079-1085.
222. Kushida CA, Nichols DA, Quan SF, et al. The apnea positive pressure long-term efficacy study (APPLES): Rationale, design, methods, and procedures. J Clin Sleep Med. 2006;2:288-300. (Pubitemid 44299552)
223. Phillips B. Your tax dollars at work!or the APPLES trial bears fruit. J Clin Sleep Med. 2008;4:419-420.
224. Permut I, Diaz-Abad M, Chatila W, et al. Comparison of positional therapy to CPAP in patients with positional obstructive sleep apnea. J Clin Sleep Med. 2010;6:238-243.
225. Poirier P, Cornier MA, Mazzone T, et al. on behalf of the American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors. A scientific statement from the American Heart Association. Circulation. 2011;123:1683-1701.